Survival t(8;16)(p11;p13) patients as compared with a pediatric AML reference cohort. Survival curves of t(8;16)(p11;p13) patients diagnosed after January 1, 1993, and treated up front with chemotherapy compared with 543 unselected pediatric AML patients treated by the AML-BFM study group between 1995 and 2005.